✦ LIBER ✦

P-584 Single agent gemcitabine (GEM) in performance status (PS) 2–3patients (pts) with advanced non-small cell lung cancer (NSCLC): Effect on disease-related symptoms in a multicenter phase II trial

✍ Scribed by Tiseo, M.; Tognoni, A.; Carob, C.; Mencoboni, M.; Pennucci, M.; Coialbu, T.; Brema, F.; Grossi, F.; Pronzato, P.; Ardizzoni, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised phase II trial of 4 dose leve

✍ Califano, Raffaele; Griffiths, Richard; Lorigan, Paul; Ashcroft, Linda; Taylor, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 488 KB

Sequential therapy with Vinorelbine foll

✍ Hirsh, Vera; Latreille, Jean; Kreisman, Harvey; Desjardins, Pierre; Ofiara, Lind 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 121 KB

P-228 Preliminary results of A phase II

✍ Joppert, Marcos; Marsland, Thomas; Whittaker, Thomas; Ahmad, Haroon; Neubauer, M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

P-548 A multicenter phase II study of do

✍ Le Caer, H.; Gimenez, C.; Chouaid, C.; Jullian, H.; Le Treut, J.; Bombaron, P.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Randomized phase II trial of gefitinib o

✍ Morère, Jean-François; Bréchot, Jeanne-Marie; Westeel, Virginie; Gounant, Valeri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Phase II trial of gemcitabine/carboplati

✍ Bridges, Benjamin B.; Thomas, Leno; Hausner, Petr F.; Doyle, L. Austin; Bedor, M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 194 KB